November 29, 2024 Holiday Shopping Sets New Records With $6.1B Spent Online
November 25, 2024 Bitcoin Nears $100K: Crypto Revolution Reshapes Wall Street
November 18, 2024 Biden’s Missile Strategy: Escalation Or Path To Peace?
November 10, 2024 Wall Street Soars: Trump’s Victory Ignites Market Surge
Nvidia’s Pullback: The Calm Before Takeoff
Tesla Faces An Uphill Battle In 2025
Amazon: A Compelling Buying Opportunity
Xiaomi: Anatomy Of A Tesla Killer
October 22, 2024 A Comprehensive Guide to RoadRunner Auto Transport Services
October 3, 2024 Mastering Trading Indicators: Your Essential Toolkit For Success
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
Tilray (TLRY) Stock Forecast for 2024, 2025, 2026. Sell or Buy?
Updated: December 5, 2024 (10:04)
Sector: HealthcareThe share price of Tilray, Inc. (TLRY) now
News Impact Analyzer
Full report|
This Week
|
Na | Impact: Na | News: Na |
|
Previous Week
|
Bullish | Impact: 5 | News: 2 (1/1/0) |
|
Two Weeks Ago
|
Na | Impact: Na | News: Na |
|
Three Weeks Ago
|
Bearish | Impact: 1.13 | News: 2 (1/0/1) |
Analysts predictions
Full report|
This Week
|
Neutral | Opinions: Na |
|
Previous Week
|
Neutral | Opinions: Na |
|
Two Weeks Ago
|
Neutral | Opinions: Na |
|
Three Weeks Ago
|
Neutral | Opinions: Na |
Analyzing the Most Important TLRY news
Insider Trading Highlights: Top Buys and Sells of the Week
Tilray Brands Gains Momentum After Breaking Losing Streak
Tilray's Cannabis Breakthrough in Chemo Nausea
Historical and forecast chart of Tilray stock
The chart below shows the historical price of Tilray stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Tilray stock price can be found in the table below.
Long-term forecasts by years.
Tilray, Inc. Analysts predictions review
As of now, Panda has combed through 0 analytical articles which are directly related to TLRY from the last 30 days. Out of these, 0 clearly showcase a bullish trend, while 0 see a bearish trend as the more likely scenario, and 0 stay neutral.
To identify the dominant trend, we took into account analytical articles from the past 30 days, spanning from Jan 01, 1970 to Jan 01, 1970.
Tilray Brands: Overvalued and Underperforming - What's Next?
In his latest analytical piece, Alan Brochstein, CFA, shares his insights on TLRY stock, highlighting a consistent 'No' stance. Given his extensive experience, with 769 publications since 2007, Brochstein has established himself as a prolific and influential voice in the financial analyst community. His growing subscriber base of over 71,000 attests to the popularity and trust his analyses command among readers. With a credibility ranking considered high, his well-formed opinions are highly regarded, reflecting a deep understanding of market dynamics. This level of expertise ensures that when Brochstein voices a viewpoint, such as his cautionary stance on TLRY, it warrants attention from those seeking informed financial guidance.
Key Theses on Tilray Brands
- Tilray Brands' financial results have underperformed expectations, contributing to a negative outlook on its stock.
- The company's diversification away from cannabis has not significantly improved its market position.
- Tilray's stock remains overvalued in comparison to its peers, despite a significant decline in price.
Factors Influencing Tilray's Stock Price
Underperformance in Q1 Financial Results
Tilray reported Q1 revenue of $200 million, which was below the anticipated $227 million, indicating a significant shortfall against expectations. This underperformance affects investor confidence, potentially leading to a decrease in stock price.
Business Diversification
While Tilray has diversified into segments such as Beverage and Distribution, this has not compensated for the underperformance in cannabis and has resulted in uneven revenue contributions, limiting overall growth potential. The impact strength is moderate as these segments contribute varying degrees to overall revenue.
Comparative Valuation
Tilray trades at 2.7X tangible book value compared to peers like Village Farms at 0.5X, making it appear overvalued. This comparative overvaluation is significant as it discourages potential investors who seek more appropriately priced alternatives.
Market Expansion Uncertainty
Future growth prospects, such as the introduction of THC beverages and U.S. market penetration, hold potential but face uncertain regulatory and consumer market dynamics. This factor moderately impacts stock price, as successful market expansion could increase revenues, but uncertainty limits immediate stock value.
Analyst Revenue and Earnings Outlook
Analysts have reduced their revenue projections from $930 million to $904 million for FY25, and forecasted continued losses, impacting investor sentiment negatively. These downgraded expectations significantly affect stock valuation as they suggest persistent financial struggles.
Review the original Analysis
Tilray's Mixed Outlook: Revenue Miss and Cash Concerns
In his latest analytical financial article, Bill Maurer offers a thorough assessment of TLRY stock, maintaining a Neutral stance on its prospects. With a proven record of contributing over 3,269 publications since 2011, Maurer showcases an impressive frequency of insightful analyses. His perspectives command significant attention, underscored by a robust subscriber base of 35,711. This level of engagement not only attests to his popularity but also signifies a high credibility for his evaluations. Maurer's authoritative voice in financial discourse reflects an exceptional ability to navigate and convey complex market dynamics with clarity. Readers can rely on his articulate and balanced viewpoints as he dissects TLRY stock's current position and potential outlook, grounding his insights in a rich blend of experience and data-driven analysis.
Key Theses on Tilray's Performance
- Tilray's Q1 revenue fell short of estimates, with cannabis revenue declining despite beverage-related growth.
- The company showed an increased GAAP operating loss but had a reduction in GAAP net loss and faced significant cash burn and shareholder dilution.
- Tilray's valuation gap compared to Canopy Growth is narrowing, with analysts maintaining a cautiously positive outlook but reducing price targets over time.
Factors Influencing Tilray's Stock Price
Revenue Miss
The $21 million revenue miss indicates challenges in achieving expected growth, particularly due to a substantial decline in cannabis revenue. This shortfall negatively affects investor confidence and directly impacts the company's stock price in the near term.
Cash Burn and Dilution
Tillray's $40 million cash burn and significant dilution with over 36 million shares issued signal financial instability and shareholder value erosion, which are critical concerns for investors and exert strong downward pressure on stock prices.
Valuation Relative to Peers
Tilray's narrowing valuation discount to Canopy Growth indicates a relative improvement. However, the persistent lower valuation suggests market skepticism, impacting investor decisions and stock performance moderately.
Analyst Sentiment and Price Targets
Although analysts are generally positive, the reduction in average price targets reflects tempered expectations, potentially influencing investor sentiment and creating a restrained impact on the stock price.
Beverage Margins
The decline in adjusted beverage margins due to one-time items initially undermines profitability in this growing segment. However, with these agreements ending, future margin improvements may mitigate the impact on the stock price.
Review the original Analysis Commentary
Tilray's latest quarterly report paints an intriguing picture. While growth in the beverage sector shines a positive light, the $21 million revenue miss and a worrying cash burn of $40 million weigh heavily on the company's immediate outlook. The combination of increasing financial instability and significant shareholder dilution compounds the concern, signaling a cloudy path ahead for investors. These factors, with high significance ratings, suggest considerable pressure on the stock in the coming fortnight.
Despite these headwinds, Tilray's narrowing valuation gap compared to Canopy Growth offers a glimmer of hope, suggesting some level of market resilience. However, tempered analyst expectations and reduced price targets contribute to a prevailing atmosphere of caution. Over the long haul, potential improvements in beverage margins might alleviate some financial strains, offering an avenue for recovery. With an average significance of the factors leaning towards modest influence, the stock is likely to maintain a neutral stance over the coming month, pending significant strategic shifts or market developments.
Comprehensive Analysis of Tilray (TLRY) Stock Market Performance
Our multifaceted analysis of Tilray's stock market is grounded in the company's key news stories, insights from reputable analysts, as well as mathematical and technical evaluations. Taking into account assessments from each of these aspects in real-time helps us address the most crucial questions for investors in the most objective way possible:
- When should I take profit in Tilray stock?
- When should I record a loss on Tilray stock?
- What are analysts' forecasts for Tilray stock?
- What is the future of Tilray stock?
We forecast Tilray stock performance using neural networks based on historical data on Tilray stocks.
Tilray, Inc. News influencing stock rates
As of now, Panda has combed through 4 news items directly related to TLRY from the last 30 days. Out of these, 2 clearly showcase a bullish trend, while 1 display bearish tendencies, and 1 events are neutral.
The strength of the bullish trend outpaces the bearish sentiments by 1.56 times, indicating that the news backdrop is positively influencing the company’s stock price in the current outlook.
The news analyzed fell within the period from Nov 06, 2024, to Nov 23, 2024.
Cannabis Stocks Tumble After Florida Rejects Marijuana Bill
Tilray Faces Hurdles: Cannabis Segment Struggles in Latest Quarter
Tilray Eyes Growth Amid US Presidential Race and Cannabis Reforms
Tilray Brands' Revenue Rise Tempers Net Loss Shrank by 38%
Tilray Counts on Earnings Upswing: Q1 Report to Reveal All
Tilray Expands Footprint with Redecan Launch in Australia
Americans Shift Toward Negative Views on Marijuana: Gallup
Cannabis Stocks React as DEA Schedules Hearing on Marijuana Rescheduling
Tilray Expands Craft Beer Empire with Molson Coors Acquisition
Stocks Jump as Investors Await Fed Meeting: TLRY, PYPL, SOFI Soar
Unpacking Tilray Stocks: A Glimpse into the Future of Cannabis and Beverage Shares
In the ever-volatile world of the stock market, predicting the future direction of any stock, including Tilray Brands, Inc. (NASDAQ:TLRY), presents a spectrum of uncertainties. With TLRY’s recent financial disclosures and strategic shifts, investors find themselves at a crossroads, attempting to discern the potential pathways for TLRY stock prices and pondering the lingering question: is TLRY stock a buy?
Complex Dynamics Influencing TLRY Stock Predictions
A dive into Tilray’s recent financial quarter reveals a narrative of growth driven predominantly through acquisitions rather than organic expansion, notably within the cannabis domain. The firm’s pivot towards the beverage sector, marked by acquiring craft beer brands from Anheuser-Busch, reflects a strategic realignment that echoes throughout TLRY’s financial performance and, by extension, its stock valuation. This shift has sparked questions regarding the TLRY stock forecast, as investors wonder whether these acquisitions can morph into long-term gains.
TLRY’s Q2 reporting season shed light on a 34% year-over-year revenue increase, totaling $194 million, a figure slightly shy of analyst estimates. Despite this growth, TLRY’s struggle with cash burn, debt accumulation, and the specter of shareholder dilution looms large, influencing the TLRY stock prediction dialogues.
Especially pivotal to TLRY stock price prediction will be the unfolding landscape of U.S. federal cannabis legalization and potential major equity raises. These events bear the weight to either significantly propel the company forward or place further strains on its financial structure.
Predicting the trajectory of TLRY stock rates demands a nuanced understanding of both its evolving business model and broader market dynamics. While the recent focus on the beverage sector and cannabis revenue gains paint a mixed picture, the underlying challenges of debt management and market expansion remain key. As a result, whether investors will profit from their decisions to buy or sell TLRY stock depends largely on these upcoming events, making TLRY stock price predictions a difficult task due to the complexity and unknowns involved.
Tilray, a trailblazer in the cannabis industry, has its primary hub nestled in Nanaimo, British Columbia, Canada. This site isn’t just their headquarters; it’s also where they craft their products. Back in 2018, they proudly harvested a bountiful crop of medical cannabis at their facility in Portugal.
Their research and development haven in Nanaimo spreads across a whopping 18,300 square meters. The year 2018 was a banner year for them sales-wise, with the amount of product sold skyrocketing to 6,478 kilograms – more than double the previous year’s tally of 3,024 kilograms. It was clear that Tilray was on an impressive upward trajectory.
Tilray daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Dec 07 | 1.28 | 1.25 | 1.34 | 7.40 |
| Dec 08 | 1.31 | 1.26 | 1.33 | 5.88 |
| Dec 09 | 1.30 | 1.24 | 1.35 | 9.41 |
| Dec 10 | 1.22 | 1.18 | 1.24 | 5.52 |
| Dec 11 | 1.27 | 1.25 | 1.30 | 4.12 |
| Dec 12 | 1.30 | 1.27 | 1.34 | 4.99 |
| Dec 13 | 1.32 | 1.29 | 1.36 | 5.53 |
| Dec 14 | 1.32 | 1.26 | 1.34 | 6.13 |
| Dec 15 | 1.36 | 1.29 | 1.40 | 8.58 |
| Dec 16 | 1.31 | 1.27 | 1.36 | 6.67 |
| Dec 17 | 1.25 | 1.22 | 1.28 | 4.37 |
| Dec 18 | 1.27 | 1.20 | 1.34 | 11.02 |
| Dec 19 | 1.35 | 1.32 | 1.40 | 6.24 |
| Dec 20 | 1.32 | 1.26 | 1.38 | 10.08 |
| Dec 21 | 1.34 | 1.28 | 1.41 | 10.25 |
| Dec 22 | 1.42 | 1.35 | 1.45 | 7.06 |
| Dec 23 | 1.39 | 1.35 | 1.42 | 5.16 |
| Dec 24 | 1.44 | 1.41 | 1.49 | 5.42 |
| Dec 25 | 1.45 | 1.38 | 1.50 | 9.10 |
| Dec 26 | 1.48 | 1.44 | 1.52 | 5.08 |
| Dec 27 | 1.47 | 1.42 | 1.53 | 7.58 |
| Dec 28 | 1.45 | 1.37 | 1.49 | 8.82 |
| Dec 29 | 1.42 | 1.37 | 1.49 | 8.53 |
| Dec 30 | 1.42 | 1.36 | 1.49 | 9.21 |
| Dec 31 | 1.41 | 1.37 | 1.47 | 7.66 |
| Jan 01 | 1.36 | 1.33 | 1.44 | 8.34 |
| Jan 02 | 1.29 | 1.23 | 1.31 | 6.69 |
| Jan 03 | 1.25 | 1.20 | 1.31 | 9.01 |
| Jan 04 | 1.26 | 1.24 | 1.32 | 6.61 |
| Jan 05 | 1.26 | 1.23 | 1.30 | 6.02 |
Tilray Daily Price Targets
Tilray Stock Forecast 12-07-2024.
Forecast target price for 12-07-2024: $1.28.
Negative dynamics for Tilray shares will prevail with possible volatility of 6.892%.
Pessimistic target level: 1.25
Optimistic target level: 1.34
Tilray Stock Forecast 12-08-2024.
Forecast target price for 12-08-2024: $1.31.
Positive dynamics for Tilray shares will prevail with possible volatility of 5.554%.
Pessimistic target level: 1.26
Optimistic target level: 1.33
Tilray Stock Forecast 12-09-2024.
Forecast target price for 12-09-2024: $1.30.
Negative dynamics for Tilray shares will prevail with possible volatility of 8.599%.
Pessimistic target level: 1.24
Optimistic target level: 1.35
Tilray Stock Forecast 12-10-2024.
Forecast target price for 12-10-2024: $1.22.
Negative dynamics for Tilray shares will prevail with possible volatility of 5.232%.
Pessimistic target level: 1.18
Optimistic target level: 1.24
Tilray Stock Forecast 12-11-2024.
Forecast target price for 12-11-2024: $1.27.
Positive dynamics for Tilray shares will prevail with possible volatility of 3.960%.
Pessimistic target level: 1.25
Optimistic target level: 1.30
Tilray Stock Forecast 12-12-2024.
Forecast target price for 12-12-2024: $1.30.
Positive dynamics for Tilray shares will prevail with possible volatility of 4.753%.
Pessimistic target level: 1.27
Optimistic target level: 1.34
TLRY (TLRY) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan. | 1.69 | 1.56 | 2.08 | 24.86 |
| Feb. | 1.75 | 1.56 | 2.06 | 24.02 |
| Mar. | 1.68 | 1.46 | 1.81 | 19.48 |
| Apr. | 1.42 | 1.22 | 1.51 | 19.08 |
| May. | 1.51 | 1.17 | 1.75 | 33.39 |
| Jun. | 1.65 | 1.30 | 1.99 | 34.30 |
| Jul. | 1.82 | 1.61 | 1.99 | 19.16 |
| Aug. | 1.91 | 1.75 | 2.25 | 22.57 |
| Sep. | 1.70 | 1.57 | 1.89 | 17.23 |
| Oct. | 1.76 | 1.55 | 2.04 | 24.07 |
| Nov. | 1.26 | 1.12 | 1.39 | 19.38 |
| Dec. | 1.25 | 1.08 | 1.52 | 28.72 |
Tilray forecast for this year
Tilray Stock Prediction for Jan 2025
An uptrend is forecast for this month with an optimal target price of $1.68572. Pessimistic: $1.56. Optimistic: $2.08
Tilray Stock Prediction for Feb 2025
An uptrend is forecast for this month with an optimal target price of $1.75146. Pessimistic: $1.56. Optimistic: $2.06
Tilray Stock Prediction for Mar 2025
An downtrend is forecast for this month with an optimal target price of $1.6779. Pessimistic: $1.46. Optimistic: $1.81
Tilray Stock Prediction for Apr 2025
An downtrend is forecast for this month with an optimal target price of $1.41615. Pessimistic: $1.22. Optimistic: $1.51
Tilray Stock Prediction for May 2025
An uptrend is forecast for this month with an optimal target price of $1.50961. Pessimistic: $1.17. Optimistic: $1.75
Tilray Stock Prediction for Jun 2025
An uptrend is forecast for this month with an optimal target price of $1.64548. Pessimistic: $1.30. Optimistic: $1.99
Tilray Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $1.81826. Pessimistic: $1.61. Optimistic: $1.99
Tilray Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $1.90553. Pessimistic: $1.75. Optimistic: $2.25
Tilray Stock Prediction for Sep 2025
An downtrend is forecast for this month with an optimal target price of $1.69973. Pessimistic: $1.57. Optimistic: $1.89
Tilray Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $1.75583. Pessimistic: $1.55. Optimistic: $2.04
Tilray Stock Prediction for Nov 2025
An downtrend is forecast for this month with an optimal target price of $1.26068. Pessimistic: $1.12. Optimistic: $1.39
Tilray Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $1.24555. Pessimistic: $1.08. Optimistic: $1.52
Tilray (TLRY) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.15 | 0.92 | 1.25 | 26.29 |
| Feb | 0.99 | 0.78 | 1.07 | 27.40 |
| Mar | 1.15 | 1.03 | 1.36 | 24.60 |
| Apr | 1.22 | 1.09 | 1.47 | 25.91 |
| May | 1.50 | 1.40 | 1.70 | 17.49 |
| Jun | 1.91 | 1.64 | 2.05 | 20.09 |
| Jul | 2.48 | 2.02 | 2.85 | 29.03 |
| Aug | 2.14 | 1.88 | 2.53 | 25.68 |
| Sep | 1.73 | 1.33 | 1.86 | 28.19 |
| Oct | 1.83 | 1.69 | 2.06 | 18.12 |
| Nov | 1.45 | 1.17 | 1.57 | 25.60 |
| Dec | 1.83 | 1.55 | 2.24 | 30.69 |
Tilray (TLRY) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 1.58 | 1.22 | 1.73 | 29.75 |
| Feb | 1.74 | 1.50 | 2.06 | 26.95 |
| Mar | 2.13 | 1.64 | 2.62 | 37.13 |
| Apr | 2.17 | 2.03 | 2.48 | 18.36 |
| May | 2.41 | 2.25 | 2.87 | 21.64 |
| Jun | 2.52 | 2.04 | 2.99 | 31.87 |
| Jul | 2.63 | 2.04 | 3.09 | 33.99 |
| Aug | 2.82 | 2.46 | 3.45 | 28.72 |
| Sep | 3.14 | 2.52 | 3.39 | 25.60 |
| Oct | 3.68 | 2.90 | 4.47 | 35.28 |
| Nov | 4.54 | 3.87 | 5.33 | 27.34 |
| Dec | 5.58 | 4.99 | 6.51 | 23.37 |
Tilray information and performance
1100 MAUGHAN ROAD, NANAIMO, BC, CA
Market capitalization of the Tilray, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of TLRY shares in the company outstanding by the market price of one share.
EBITDA of Tilray is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Commentary
Despite efforts to expand into non-cannabis ventures, Tilray Brands has been struggling to gain solid financial footing. The company's underwhelming Q1 results, with revenues falling short by $27 million, have left investors disenchanted. Tilray's attempt at diversification through beverages and distribution seems to have merely led to uneven revenue streams, offering little in terms of real growth, making its stock appear overpriced compared to its peers. Analysts bolstering this concern have pulled down their revenue forecasts, pointing to ongoing financial turbulence ahead.
Factoring in these insights, we've made an average strength assessment of 6.6 on factors influencing Tilray's stock. In terms of upcoming market behavior, this indicates a potentially bearish outlook in the short term, such as the next 15 days, and similarly over the next month. With much depending on how the company resolves its market expansion plans and tackles financial headwinds, the path forward remains uncertain and investors may want to keep expectations measured.